Clinical trial
Creatine for the Treatment of Amyotrophic Lateral Sclerosis
NCT00070993 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00070993 |
|---|---|
| Title | Creatine for the Treatment of Amyotrophic Lateral Sclerosis |
| Official title | Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Collaborators | Office of Dietary Supplements (ODS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis |
| Intervention type | Drug |
| Interventions | creatine monohydrate |
| Enrollment | 110 |
| Start date | Dec 1, 2002 |
| Completion | May 1, 2006 |
| First posted | Oct 13, 2003 |
| Last update posted | Aug 4, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: